
Renewal by Andersen’s ‘Made in USA’ Window Dressing
TINA.org files FTC complaint against company.
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)
TINA.org files FTC complaint against company.
Don’t let the American flags fool you.
Can supplements really help your child reach new heights?
How brands exploit kid influencers and their followers.
TINA.org digs into online retailer’s U.S.-origin claims following consumer tip.